208 related articles for article (PubMed ID: 22649499)
21. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
22. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.
Maisonneuve C; Bertholet S; Philpott DJ; De Gregorio E
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12294-9. PubMed ID: 25136133
[TBL] [Abstract][Full Text] [Related]
23. Prenatal exposure to bisphenol-A is associated with Toll-like receptor-induced cytokine suppression in neonates.
Liao SL; Tsai MH; Lai SH; Yao TC; Hua MC; Yeh KW; Chiang CH; Huang SY; Huang JL
Pediatr Res; 2016 Mar; 79(3):438-44. PubMed ID: 26571221
[TBL] [Abstract][Full Text] [Related]
24. Innate immune responses to malaria-infected erythrocytes in pregnant women: Effects of gravidity, malaria infection, and geographic location.
Jabbarzare M; Njie M; Jaworowski A; Umbers AJ; Ome-Kaius M; Hasang W; Randall LM; Kalionis B; Rogerson SJ
PLoS One; 2020; 15(7):e0236375. PubMed ID: 32726331
[TBL] [Abstract][Full Text] [Related]
25. Malaria modifies neonatal and early-life toll-like receptor cytokine responses.
Gbédandé K; Varani S; Ibitokou S; Houngbegnon P; Borgella S; Nouatin O; Ezinmegnon S; Adeothy AL; Cottrell G; Massougbodji A; Moutairou K; Troye-Blomberg M; Deloron P; Fievet N; Luty AJ
Infect Immun; 2013 Aug; 81(8):2686-96. PubMed ID: 23690399
[TBL] [Abstract][Full Text] [Related]
26. Infants with low vaccine antibody responses have altered innate cytokine response.
Surendran N; Nicolosi T; Pichichero M
Vaccine; 2016 Nov; 34(47):5700-5703. PubMed ID: 27745950
[TBL] [Abstract][Full Text] [Related]
27. The nucleotide-binding domain and leucine-rich repeat protein-3 inflammasome is not activated in airway smooth muscle upon toll-like receptor-2 ligation.
Hirota JA; Im H; Rahman MM; Rumzhum NN; Manetsch M; Pascoe CD; Bunge K; Alkhouri H; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):517-24. PubMed ID: 23614732
[TBL] [Abstract][Full Text] [Related]
28. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
[TBL] [Abstract][Full Text] [Related]
30. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
31. Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes.
Wang J; Chen Z; Walston JD; Gao P; Gao M; Leng SX
Mol Neurobiol; 2019 Nov; 56(11):7664-7679. PubMed ID: 31098954
[TBL] [Abstract][Full Text] [Related]
32. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Ghosh TK; Mickelson DJ; Solberg JC; Lipson KE; Inglefield JR; Alkan SS
Int Immunopharmacol; 2007 Aug; 7(8):1111-21. PubMed ID: 17570328
[TBL] [Abstract][Full Text] [Related]
33. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.
Angelone DF; Wessels MR; Coughlin M; Suter EE; Valentini P; Kalish LA; Levy O
Pediatr Res; 2006 Aug; 60(2):205-9. PubMed ID: 16864705
[TBL] [Abstract][Full Text] [Related]
34. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.
van Haren SD; Ganapathi L; Bergelson I; Dowling DJ; Banks M; Samuels RC; Reed SG; Marshall JD; Levy O
Cytokine; 2016 Jul; 83():99-109. PubMed ID: 27081760
[TBL] [Abstract][Full Text] [Related]
35. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.
Ovsyannikova IG; Dhiman N; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
Hum Genet; 2010 Feb; 127(2):207-21. PubMed ID: 19902255
[TBL] [Abstract][Full Text] [Related]
36. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals.
Khoo AL; Chai LY; Koenen HJ; Sweep FC; Joosten I; Netea MG; van der Ven AJ
Clin Exp Immunol; 2011 Apr; 164(1):72-9. PubMed ID: 21323660
[TBL] [Abstract][Full Text] [Related]
37. Differences in innate cytokine responses between European and African children.
Labuda LA; de Jong SE; Meurs L; Amoah AS; Mbow M; Ateba-Ngoa U; van der Ham AJ; Knulst AC; Yazdanbakhsh M; Adegnika AA
PLoS One; 2014; 9(4):e95241. PubMed ID: 24743542
[TBL] [Abstract][Full Text] [Related]
38. IL-18 triggered by the Nlrp3 inflammasome induces host innate resistance in a pulmonary model of fungal infection.
Ketelut-Carneiro N; Silva GK; Rocha FA; Milanezi CM; Cavalcanti-Neto FF; Zamboni DS; Silva JS
J Immunol; 2015 May; 194(9):4507-17. PubMed ID: 25825440
[TBL] [Abstract][Full Text] [Related]
39. GPRC6A mediates Alum-induced Nlrp3 inflammasome activation but limits Th2 type antibody responses.
Quandt D; Rothe K; Baerwald C; Rossol M
Sci Rep; 2015 Nov; 5():16719. PubMed ID: 26602597
[TBL] [Abstract][Full Text] [Related]
40. [Pattern recognition receptors].
Hayashi T; Nakamura T; Takaoka A
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):329-45. PubMed ID: 22041420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]